421 related articles for article (PubMed ID: 25004868)
41. Women's knowledge of Pap smear test and human papillomavirus: acceptance of HPV vaccination to themselves and their daughters in an Islamic society.
Ilter E; Celik A; Haliloglu B; Unlugedik E; Midi A; Gunduz T; Ozekici U
Int J Gynecol Cancer; 2010 Aug; 20(6):1058-62. PubMed ID: 20683417
[TBL] [Abstract][Full Text] [Related]
42. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England.
Spencer Nee Pilkington AM; Brabin L; Verma A; Roberts SA
Eur J Cancer; 2013 Apr; 49(6):1264-72. PubMed ID: 23290788
[TBL] [Abstract][Full Text] [Related]
43. Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study.
Chan DNS; Lee PPK; So WKW
J Racial Ethn Health Disparities; 2024 Jun; 11(3):1465-1477. PubMed ID: 37195592
[TBL] [Abstract][Full Text] [Related]
44. Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.
Petagna CN; Perez S; Hsu E; Greene BM; Banner I; Bednarczyk RA; Escoffery C
BMC Cancer; 2024 May; 24(1):592. PubMed ID: 38750439
[TBL] [Abstract][Full Text] [Related]
45. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
46. Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review.
Patel H; Jeve YB; Sherman SM; Moss EL
Sex Transm Infect; 2016 Sep; 92(6):474-9. PubMed ID: 26792088
[TBL] [Abstract][Full Text] [Related]
47. Factors Motivating HPV Vaccine Uptake Among Vaccinated and Nonvaccinated Hispanic Young Adult Women.
Stephens DP; Tamir H; Thomas TL
Hisp Health Care Int; 2016 Dec; 14(4):184-191. PubMed ID: 27913692
[TBL] [Abstract][Full Text] [Related]
48. The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.
Dilley SE; Peral S; Straughn JM; Scarinci IC
Prev Med; 2018 Aug; 113():124-131. PubMed ID: 29800594
[TBL] [Abstract][Full Text] [Related]
49. Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.
Remschmidt C; Fesenfeld M; Kaufmann AM; Deleré Y
BMC Public Health; 2014 Dec; 14():1248. PubMed ID: 25476713
[TBL] [Abstract][Full Text] [Related]
50. Barriers and facilitators to HPV vaccine uptake among US rural populations: a scoping review.
Peterson CE; Silva A; Holt HK; Balanean A; Goben AH; Dykens JA
Cancer Causes Control; 2020 Sep; 31(9):801-814. PubMed ID: 32537702
[TBL] [Abstract][Full Text] [Related]
51. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.
Mabeya H; Menon S; Weyers S; Naanyu V; Mwaliko E; Kirop E; Orango O; Vermandere H; Vanden Broeck D
BMC Cancer; 2018 May; 18(1):557. PubMed ID: 29751793
[TBL] [Abstract][Full Text] [Related]
52. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya.
Vermandere H; Naanyu V; Mabeya H; Vanden Broeck D; Michielsen K; Degomme O
PLoS One; 2014; 9(10):e109353. PubMed ID: 25299646
[TBL] [Abstract][Full Text] [Related]
53. Barriers and facilitators to HPV vaccination: perspectives from Malawian women.
Ports KA; Reddy DM; Rameshbabu A
Women Health; 2013; 53(6):630-45. PubMed ID: 23937733
[TBL] [Abstract][Full Text] [Related]
54. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.
Fisher H; Trotter CL; Audrey S; MacDonald-Wallis K; Hickman M
Int J Epidemiol; 2013 Jun; 42(3):896-908. PubMed ID: 23620381
[TBL] [Abstract][Full Text] [Related]
55. Communication around HPV vaccination for adolescents in low- and middle-income countries: a systematic scoping overview of systematic reviews.
Foss HS; Oldervoll A; Fretheim A; Glenton C; Lewin S
Syst Rev; 2019 Aug; 8(1):190. PubMed ID: 31370886
[TBL] [Abstract][Full Text] [Related]
56. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N
Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591
[TBL] [Abstract][Full Text] [Related]
57. HPV vaccine acceptability in Ghana, West Africa.
Coleman MA; Levison J; Sangi-Haghpeykar H
Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
[TBL] [Abstract][Full Text] [Related]
58. Barriers and facilitators to uptake of the school-based HPV vaccination programme in an ethnically diverse group of young women.
Batista Ferrer H; Trotter CL; Hickman M; Audrey S
J Public Health (Oxf); 2016 Sep; 38(3):569-577. PubMed ID: 26054910
[TBL] [Abstract][Full Text] [Related]
59. A Qualitative Analysis of Young Sexual Minority Men's Perspectives on Human Papillomavirus Vaccination.
Gerend MA; Madkins K; Crosby S; Korpak AK; Phillips GL; Bass M; Houlberg M; Mustanski B
LGBT Health; 2019 Oct; 6(7):350-356. PubMed ID: 31556791
[No Abstract] [Full Text] [Related]
60. Adolescent Health Series: HPV infection and vaccination in sub-Saharan Africa: 10 years of research in Tanzanian female adolescents - narrative review.
Whitworth H; Changalucha J; Baisley K; Watson-Jones D
Trop Med Int Health; 2021 Nov; 26(11):1345-1355. PubMed ID: 34310816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
